Can Colombia turn a decade of medical reform into an adult-use breakthrough?
Colombia medical cannabis has quietly grown into one of Latin America’s most established regulated markets, and in 2026 the country is testing whether that foundation can carry full adult-use reform. A landmark 2025 decree opened domestic pharmacy sales of dried flower, and a fresh legalisation bill has cleared its first congressional hurdle. For cultivators and processors eyeing European buyers, the stakes have rarely been higher.
What is the state of Colombia medical cannabis regulation in 2026?
Colombia medical cannabis has been legal since 2016, and the framework now covers domestic flower sales as well as exports. Law 1787 of 2016, signed on 6 July 2016, authorised the cultivation, manufacture, export and medical use of cannabis and its derivatives, and Decree 613 of 2017 built out the licensing system. The most significant recent change arrived with Decree 1138 of 2025, effective 27 October 2025, which for the first time allowed dried cannabis flower to be dispensed as a finished product in Colombian pharmacies rather than only exported or sold as oils and extracts. To protect the domestic industry, the decree grants micro, small and medium-sized cultivators exclusive access to supply that market for its first two years.
Who regulates cannabis in Colombia?
| Body | Role in the medical cannabis chain |
|---|---|
| Ministerio de Justicia y del Derecho | Issues licences for psychoactive cannabis cultivation, including seeds, plants and derivative production |
| Ministerio de Salud y Proteccion Social | Issues licences for manufacturing cannabis derivatives |
| INVIMA | Health-product oversight; sanitary registration of finished cannabis products |
| ICA | Agricultural and phytosanitary control, including export certification for plant-origin shipments |
| Fondo Nacional de Estupefacientes (FNE) | Authorises the per-shipment export quota required for each consignment |
Will Colombia legalise adult-use cannabis?
Not yet, and passage is far from certain. On 12 May 2026, the First Committee of Colombia’s House of Representatives approved an adult-use regulation bill in the first of four required debates, the furthest such a proposal has reached after a string of earlier attempts were archived. The ordinary bill, Proyecto de Ley 023 de 2025 filed by Representative Alejandro Ocampo, still needs to clear the full House and then the Senate. Conservative blocs have defeated or shelved every prior reform since 2020, so the outcome remains open. For producers, the practical takeaway is that the export-focused medical market, not domestic recreational sales, is where near-term commercial demand still sits.
What does this mean for cannabis producers?
Colombia’s competitive edge is cost and climate, but access to lucrative markets like Germany runs through quality and documentation. European buyers increasingly expect EU-GMP certification, and demand there keeps climbing, with the German import race pulling in supply from diversifying origins. Colombian growers who can prove seed-to-shipment traceability are best placed to win that business.
Priorities for Colombian cultivators and processors
- Confirm your licence stack. Cultivation licences sit with the Ministerio de Justicia, manufacturing with the Ministerio de Salud, and finished products need INVIMA sanitary registration.
- Plan around the FNE export quota. Each consignment requires an authorised quota and an import permit from the destination country.
- Meet the buyer’s standard. For most EU markets that means EU-GMP processing and complete batch records, not just Colombian licences.
- Keep phytosanitary paperwork current with ICA so plant-origin shipments clear certification without delay.
How GrowerIQ helps producers stay export-ready
GrowerIQ gives Colombian cultivators and processors a seed-to-sale quality management system built for regulated export. Batch and lot traceability, digital quality documents and audit-ready records make it easier to satisfy INVIMA registration, ICA phytosanitary certification and the evidence EU-GMP auditors and European importers expect. When a foreign regulator or buyer asks who grew a lot, how it was processed and how it was tested, the answer is a few clicks away rather than a scramble through spreadsheets.
Key takeaways
- Colombia legalised medical cannabis under Law 1787 of 2016, covering cultivation, manufacture, export and medical use.
- Decree 1138 of 2025 (effective 27 October 2025) allowed dried flower to be sold as a finished product in pharmacies, with a two-year priority window for small and medium growers.
- An adult-use bill cleared the first of four debates on 12 May 2026, but conservative opposition leaves passage uncertain.
- Exports remain the near-term commercial prize; success depends on EU-GMP quality and traceability that satisfy INVIMA, ICA and European buyers.
Sources
- Colombia Authorizes Exports of Dried Cannabis Flower for Medicine, Cannabis Business Times
- Colombia Approves Sale of Medical Cannabis Flower: Small Growers Get First Dibs, High Times
- Colombia 2025: New Foreign Trade Rules and Pharmacy Flower, CannabisRegulations.ai
- Adult-Use Cannabis Legalization Measure Advances In Colombia, International CBC
- Germany Imports 201 Tonnes of Medical Cannabis in 2025, Cannamonitor
Last updated: July 17, 2026
Take your Colombian harvest export-ready
See how GrowerIQ gives Colombian producers the traceability and quality records European buyers demand.
REQUEST DEMO
About GrowerIQ
GrowerIQ is changing the way producers use software - transforming a regulatory requirement into a robust platform to learn, analyze, and improve performance.
To find out more about GrowerIQ and how we can help, fill out the form to the right, start a chat, or contact us.